At one time, Daljeet Kohli was very popular amongst rank and file investors. His block-buster stock picks like Ajanta Pharma, Alembic Pharma, Shilpa Medicare, JB Chemicals, Gujarat Pipavav, Aurobindo Pharma, CARE Ratings etc made him their darling and they latched on to every word that he uttered.
However, Daljeet’s good luck then ran out. Sharon Bio-Medicine, one of his stock picks, turned out to be a miserable failure. Several of his other stock picks like HSIL, Meghmani Organics, Indoco Remedies etc became sluggish and lost a lot of ground.
Investors, known for their merciless and fickle ways, wrote him off as a has-been.
To his credit, Daljeet has been working tenaciously on his stock picks and is trying to claw back into reckoning.
I reported earlier that Mastek/ Majesco, the stock that he recommended in July 2014, has given a magnificent return of 258%. In his latest interview, Daljeet claimed that more upside is due from Majesco. He pointed out that while the CMP is Rs. 529, his tentative target price is Rs. 800-900, a good 70% away. He implored investors to buy/ hold the stock. In an earlier interview, Daljeet explained that Majesco has a “lot of potential” and called it a “safe bet”.
OnMobile Global is the other stock pick that has filled Daljeet’s pockets with gold. It spurted 20% on Friday to reach Rs. 127.
Daljeet became famous for his OnMobile Global recommendation because for the first time, he implored investors to “Be Greedy and grab the stock”.
It is rare to see such unbridled confidence in a stock picker. Well, Daljeet has been well rewarded because while his one-year target price (in May 2015) was Rs. 101, the stock is already sitting pretty at Rs. 127.
What is astonishing is that at the time that Daljeet first put out the recommendation on 3rd November 2014, the stock was languishing at Rs. 39. So, the stock has given a fantastic return of 173% in the period of a little more than a year.
It is noteworthy is that both stocks, Mastek/ Majesco and OnMobile Global, were not conventional stock picks. They were fundamentally weak and had been written off by the investing community (In fact, Ashish Dhawan of ChrysCapital had dumped his truckload of Mastek stock in despair). Daljeet spotted the potential of these stocks and recommended a buy on the basis that there would be a “turnaround” in their fortunes due to some impending corporate action.
The result is that we can no longer ignore Daljeet’s stock picks. We will have to put him once again in our radar and stay alert for his stock picks!